<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Cardiovasc Med</journal-id><journal-id journal-id-type="iso-abbrev">Front Cardiovasc Med</journal-id><journal-id journal-id-type="publisher-id">Front. Cardiovasc. Med.</journal-id><journal-title-group><journal-title>Frontiers in Cardiovascular Medicine</journal-title></journal-title-group><issn pub-type="epub">2297-055X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12098345</article-id><article-id pub-id-type="doi">10.3389/fcvm.2025.1575757</article-id><article-categories><subj-group subj-group-type="heading"><subject>Cardiovascular Medicine</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Medium and long-term aortic remodeling following aortic valve replacement combined with anticoagulation for DeBakey I aortic dissection</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yuanyuan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/750965/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Shifeng</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Ji</surname><given-names>Congshan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Haoyuan</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2833716/overview"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Jinshu</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Juncheng</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Ximing</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1" ref-type="corresp">*</xref><uri xlink:href="https://loop.frontiersin.org/people/1414510/overview"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Long</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="cor1" ref-type="corresp">*</xref><uri xlink:href="https://loop.frontiersin.org/people/2121362/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1"><label><sup>1</sup></label><institution>Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University</institution>, <addr-line>Jinan</addr-line>, <country>China</country></aff><aff id="aff2"><label><sup>2</sup></label><institution>Department of Cardiovascular Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University</institution>, <addr-line>Jinan</addr-line>, <country>China</country></aff><aff id="aff3"><label><sup>3</sup></label><institution>Department of Cardiovascular Surgery, Qilu Hospital of Shandong University</institution>, <addr-line>Jinan</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by"><p><bold>Edited by:</bold> Giuseppe Gatti, Azienda Sanitaria Universitaria Giuliano Isontina, Italy</p></fn><fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Giampiero Esposito, Monzino Cardiology Center (IRCCS), Italy</p><p>Suguru Ohira, Westchester Medical Center, United States</p></fn><corresp id="cor1"><label>*</label><bold>Correspondence:</bold> Ximing Wang <email>wxming369@163.com</email> Long Wang <email>wanglong9000@126.com</email></corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>12</volume><elocation-id>1575757</elocation-id><history><date date-type="received"><day>12</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>28</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 Li, Yang, Ji, Yang, Sun, Jiang, Wang and Wang.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Li, Yang, Ji, Yang, Sun, Jiang, Wang and Wang</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><sec><title>Background</title><p>Total arch replacement with frozen elephant trunk has achieved promising outcomes for DeBakey type I aortic dissection. However, the effects of anticoagulation on the distal false lumen and unfavorable remodeling of the distal aorta after aortic valve replacement remains insufficiently understood. This study aimed to assess the impact of anticoagulation following aortic valve replacement on medium and long-term vascular remodeling outcomes in DeBakey type I aortic dissection.</p></sec><sec><title>Methods</title><p>We conducted a retrospective analysis of patients who underwent total arch replacement with a frozen elephant trunk for DeBakey Type I aortic dissection from September 2013 to December 2024. Seventy-two patients with preoperative and at least six months postoperative aortic computed tomography angiography images were included and stratified into a valve replacement group (<italic>n</italic>&#x02009;=&#x02009;30) and a non-valve replacement group (<italic>n</italic>&#x02009;=&#x02009;42). Various parameters of the residual dissected aorta were analyzed at six specific levels to evaluate late aortic remodeling, aortic diameter, and false lumen thrombosis.</p></sec><sec><title>Results</title><p>The median follow-up period was 17 (interquartile range IQR&#x02009;=&#x02009;9&#x02013;27) months. Preoperative characteristics and complications did not significantly differ between the two groups, except for body mass index, blood pressure, and severity of aortic regurgitation. The valve replacement group had longer cardiopulmonary bypass time, aortic cross-clamping time, cardiac arrest time, larger trunk diameter, and higher intraoperative red blood cells transfusion volume compared to the non-valve replacement group. However, there were no statistically significant differences in concomitant procedures, postoperative complications, or length of hospital stay. Regarding postoperative changes in the diameter of aortic lumen and true lumen, there were statistically significant difference in the true lumen on level 1 and the aortic lumen on level 3&#x02013;5 of the valve replacement group. Additionally, the aortic lumen and true lumen on level 1 and true lumen on level 2 of the non-valve replacement group were statistically difference. There were no significant differences in the rate of aortic remodeling at each level or overall between the two groups. The postoperative false lumen thrombosis rate was higher in the mid-descending thoracic aorta and lower in the distal abdominal aorta.</p></sec><sec><title>Conclusions</title><p>Anticoagulation following aortic valve replacement for Debakey I aortic dissection has been shown to influence aortic diameter and the false lumen thrombosis rate, but it does not significantly affect the aortic remodeling rate. Overall, anticoagulation appears to be a viable treatment strategy for Debakey I aortic dissection.</p></sec></abstract><kwd-group><kwd>aortic dissection</kwd><kwd>DeBakey type I</kwd><kwd>anticoagulation</kwd><kwd>vascular remodeling</kwd><kwd>thrombosis</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Natural Science Foundation of Shandong Province</funding-source><award-id award-type="contract" rid="cn001">ZR2021QH263, ZR2021QH352</award-id></award-group><award-group><funding-source id="cn002">the National Natural Scientific Foundation of China</funding-source><award-id award-type="contract" rid="cn002">8240066, 82271993, 82471978</award-id></award-group><award-group><funding-source id="cn003">China Postdoctoral Science Foundation</funding-source><award-id award-type="contract" rid="cn003">2022M710064</award-id></award-group></funding-group><funding-group><funding-statement>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the Natural Science Foundation of Shandong Province [ZR2021QH263, ZR2021QH352], the National Natural Scientific Foundation of China [8240066, 82271993, 82471978] and China Postdoctoral Science Foundation (2022M710064).</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="6"/><equation-count count="0"/><ref-count count="39"/><page-count count="13"/><word-count count="0"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Cardiovascular Surgery</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><label>1</label><title>Introduction</title><p>Type A aortic dissection (TAAD), particularly Debakey type I aortic dissection, stands out as one of the most critical cardiovascular emergencies due to its extensive nature, carrying an hourly mortality rate of 1%&#x02013;2% in untreated patients (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). Therefore, emergency surgical intervention is often recommended in clinical practice. In recent years, Sun's procedure has emerged as first-line therapy for TAAD, demonstrating significant short-term efficacy, with early mortality rates decreasing from 11%&#x02013;36% to 6%&#x02013;8% (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>). Depending on the extent of aortic root involvement, mechanical valve-based aortic valve replacement is employed clinically when the dissection affects the aortic sinus and aortic valve, leading to moderate to severe valvular insufficiency (<xref rid="B4" ref-type="bibr">4</xref>). Advancements in surgical techniques have contributed to improved patient outcomes, yet the long-term management of residual dissections remains challenging.</p><p>It is generally understood that lifelong anticoagulation with warfarin sodium is required following aortic valve replacement, which theoretically affects postoperative distal thrombosis in false lumen (FL) and indirectly leads to pathologic aortic remodeling (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>). Residual aortic dissection poses the risk of progressive aortic dilation, rupture, or secondary aortic surgery (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B7" ref-type="bibr">7</xref>), so systematic follow-up with computed tomography angiography (CTA) is essential to mitigate long-term adverse postoperative events, including aortic lumen (AL) expansion, true lumen (TL) compression, critical limb ischemia, and aortic rupture (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B8" ref-type="bibr">8</xref>). While early and mid-term clinical outcomes and aortic remodeling in TAAD have been documented previously (<xref rid="B9" ref-type="bibr">9</xref>&#x02013;<xref rid="B11" ref-type="bibr">11</xref>), there remains a paucity of data regarding medium and long-term postoperative aortic remodeling. Furthermore, comparative studies focusing specifically on aortic valve replacement vs. non-valve replacement techniques for Debakey type I aortic dissection are scarce. Herein, our objective was to determine the efficacy anticoagulation after aortic valve replacement on medium and long-term vascular remodeling outcomes in DeBakey type I aortic dissection.</p></sec><sec sec-type="methods" id="s2"><label>2</label><title>Materials and methods</title><sec id="s2a"><label>2.1</label><title>Study population</title><p>The protocol for this single-center, retrospective, observational study was approved by the ethical committee of Shandong Provincial Hospital (Shandong, China) (approval number: 20201-361), and the individual written informed consent was waived. Patients diagnosed with Debakey type I aortic dissection who underwent Sun's procedure at our center from September 2013 to December 2024 were retrospectively reviewed. All patients underwent preoperative CTA and had at least 6 months of follow-up data available. The flowchart of the patient-selection criteria is detailed in <xref rid="F1" ref-type="fig">Figure&#x000a0;1</xref>. Eventually, this study enrolled a total of 72 subjects (male: 50; female: 22; mean age: 48.5 years&#x02009;&#x000b1;&#x02009;9.9), who were stratified into valve replacement group (<italic>n</italic>&#x02009;=&#x02009;30) and non-valve replacement group (<italic>n</italic>&#x02009;=&#x02009;42). Patients' comprehensive clinical records were also fully extracted from the clinical database, encompassing demographics, clinical characteristics, clinical outcomes, and surgical details.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>Flowcharts of the patient selection criteria.</p></caption><graphic xlink:href="fcvm-12-1575757-g001" position="float"/></fig></sec><sec id="s2b"><label>2.2</label><title>Acquisition technique and reconstruction</title><p>Retrospective ECG-gated CTA examinations were conducted with dual-source CT scanner (Definition Flash, Siemens Healthcare, Forchheim, Germany), and the scanning parameters and contrast agent injection protocols were used according to the previous literature (<xref rid="B12" ref-type="bibr">12</xref>). Prior to surgery, all patients underwent thoracoabdominal aortic CTA and echocardiography to ascertain the type of dissection, the location of the entry tear, aortic diameters, involvement of the aortic valve and branches, which served as foundational information for the surgical approach. The location of the primary entry tear was identified on the preoperative CTA, and was verified during the operation as well. Subsequently, postoperative CTA scan was conducted at least 6 months after surgery to evaluate mid to long-term progression, including changes in aortic diameters, the thrombosis status of FL in descending aortic diameter between the two groups. Images were generally reconstructed through specialized image processing program (syngo.via, SIEMENS Healthineers). This image analysis software automatically delineates the boundaries of enhanced vessels, employing a semi-automatic centerline algorithm to measure key aortic parameters along the vertical axis using the centerline as a reference. Aortic measurements were performed by two independent observers after reviewing 10 cases (about 14% of the cohort), and interobserver correlations were recorded.</p></sec><sec id="s2c"><label>2.3</label><title>Cross-sectional image analysis of remodeling</title><p>Based on morphological measurements from the preoperative and postoperative CTA images, we evaluated mid- to long-term aortic remodeling in residual descending aortic dissections. Morphological features of aortic remodeling included changes in aortic diameter at selected measurement levels (expansion of the TL and shrinkage of the FL) and formation of FL thrombosis. Cumulative occurrence rates of aortic remodeling at each level were indirectly calculated through changes in aortic diameter.</p><p>TL and FL diameters were measured on axial CT images perpendicular to the contour of the intimal flap, and the measurement criteria was the distance between the inner edges of the transverse section perpendicular to the aortic axis (<xref rid="B13" ref-type="bibr">13</xref>). To clearly describe the distal state of the residual dissection, aortic diameters were measured at the following specific anatomical levels (<xref rid="B14" ref-type="bibr">14</xref>): (1) Level 1 (L1): distal end of the stent graft; (2) Level 2 (L2): just at the level of diaphragm; (3) Level 3 (L3): proximal abdominal aorta at the level of the celiac trunk artery; (4) Level 4 (L4): abdominal aorta at the level of the superior mesenteric artery; (5) Level 5 (L5): abdominal aorta at the level of the renal artery; (6) Level 6 (L6): distal aorta at the level of the inferior mesenteric artery. Preoperative and postoperative aortic diameter measurement schematic diagram is shown in <xref rid="F2" ref-type="fig">Figure&#x000a0;2</xref>.</p><fig position="float" id="F2"><label>Figure 2</label><caption><p>Schematic diagram of aortic diameter measurement in DeBakey type I aortic dissection pre- and post-surgery. Aortic diameters measurement was taken at standardized location with respect to the aortic anatomy in each level. AL, aortic lumen; TL, true lumen; FL, false lumen.</p></caption><graphic xlink:href="fcvm-12-1575757-g002" position="float"/></fig><p>The progression of aortic dissection was evaluated using the Society for Vascular Surgery/Society of Thoracic Surgeons (SVS/STS) Aortic Dissection Classification System (<xref rid="B15" ref-type="bibr">15</xref>). According to the SVS/STS system, the extent of dissection involvement is defined as the length of the intimal tear along the centerline of the aorta. The diameter of the primary entry was determined as the maximum distance between the flap margins of the inner intimal sheet on the axial image obtained through multi-planar reconstructions (<xref rid="B12" ref-type="bibr">12</xref>). Aortic tortuosity was quantified as the ratio of the centerline length to the linear distance from the aortic arch (at the level of the left subclavian artery) to the end of the abdominal aorta (<xref rid="B16" ref-type="bibr">16</xref>). TL compression was defined as the TL having a diameter of less than 5&#x02005;mm at least at three different levels.</p><p>In this study, aortic remodeling was categorized as positive, negative, or stable. The criteria for defining aortic remodeling were consistent with those used in previous studies (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B17" ref-type="bibr">17</xref>): positive remodeling was defined if there was significant decrease in AL diameter and/or increase in TL diameter, stable if there were no significant changes in AL or TL diameters, and negative if there was significant increase in AL diameter or decrease in TL diameter. Notably, changes in AL or TL diameter greater than 10% were considered significant.</p><p>The patency status of the FL is an important predictor of regional aortic growth and reintervention rates. Therefore, assessing the extent of FL thrombosis is necessary. Partial or complete thrombosis may be overestimated based on arterial phase images alone. All patients underwent three-phase CT scans during follow-up, and the degree of thrombosis in different levels of downstream FL was comprehensively evaluated using arterial or venous phase images. The degree of FL thrombosis includes no thrombosis, partial thrombosis, malabsorption and complete obliteration (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>). No thrombosis was defined as complete opacification of the entire length of the FL. Partial thrombosis was characterized by obvious contrast agent presence within the FL with some degree of thrombus formation. Malabsorption and complete obliteration indicated absence of contrast agent within the FL on arterial or delayed images.</p></sec><sec id="s2d"><label>2.4</label><title>Surgical procedures</title><p>All patients with aortic dissection received routine medical treatment since admission, including absolute bed rest, blood pressure control, heart rate reduction, sedation, analgesia, etc. According to the results of preoperative thoracoabdominal aortic CTA, echocardiography, and intraoperative aortic root exploration of the aortic root: For patients without involvement of the aortic valve by the dissection tear, aortic root repair and Sun's procedure were performed; For patients with preoperative aortic valve disease complicated by dissection or dissection-induced moderate to severe aortic valve insufficiency, Sun's procedure combined with aortic valve replacement is performed. All surgeries were performed by two experienced surgeons. The specifics of Sun's procedure have been detailed in previous studies (<xref rid="B19" ref-type="bibr">19</xref>), involving replacement of the aortic arch and elephant trunk technique, using a covered stent graft to cover the primary tear in the dissection, isolating the FL's main blood flow and restoring blood supply to the TL. The stent length and diameter were selected based on preoperative CTA, and the stent is implanted and sutured to the distal end of the four-branched artificial graft during the operation. The time from symptom onset to surgery, cardiopulmonary bypass time, aortic cross-clamping time, cardiac arrest time, type of stent graft, landing zone position of the stent's distal end, concomitant procedures, intraoperative blood transfusions, postoperative complications, and length of hospital stay were recorded.</p><p>Following valve replacement, patients typically take oral warfarin sodium once daily, with a dosage ranging from 2.5 to 5&#x02005;mg. The dose of warfarin varies significantly between individuals. During anticoagulation therapy, regular monitoring of the International Normalized Ratio (INR) is required to dynamically adjust the warfarin dosage, with an INR target range of 1.5&#x02013;2.0. Generally, INR levels should be monitored more frequently during the early stages of treatment to ensure effective anticoagulation while avoiding excessive bleeding. The INR was considered to be stable when the INR remains within the target range with minimal fluctuation for 2&#x02013;3 consecutive measurements without dosage adjustments.</p></sec><sec id="s2e"><label>2.5</label><title>Statistical analysis</title><p>All statistical analyses were performed using GraphPad Prism 10 (GraphPad Software Inc., CA, USA) and SPSS 27.0 (SPSS Inc., Chicago, IL, USA) software packages. The normality of data distribution was verified using the one-sample Kolmogorov&#x02013;Smirnov test. Continuous variables were compared between groups using independent sample <italic>t</italic>-test, one-way analysis of variance or non-parametric Mann&#x02013;Whitney <italic>U</italic> test. Categorical variables were compared between groups using the chi-square test <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant between the data. The Kappa test was used to assess agreement between two physicians regarding the classification of branch vessel involvement, thrombosis status, and rupture location. A Kappa value &#x0003e;0.81 was considered excellent agreement. The Bland-Altman method was used to assess the consistency in measuring diameter and length between the two physicians.</p></sec></sec><sec sec-type="results" id="s3"><label>3</label><title>Results</title><sec id="s3a"><label>3.1</label><title>Patient characteristics and baseline information</title><p>During the follow-up period, a total of 72 patients diagnosed with DeBakey I aortic dissection were included and analyzed. The median follow-up duration was 17 months in both groups, with IQR: 10&#x02013;26 months in valve replacement group and IQR: 8&#x02013;27 months in non-valve replacement group. Additionally, 66% of patients undergoing imaging examinations at least 1 year after surgery. <xref rid="T1" ref-type="table">Table&#x000a0;1</xref> displays demographic characteristics, comorbidities, and laboratory data of the patients. The study cohort predominantly consisted of males (69.4%) with a mean age of 48.5&#x02009;&#x000b1;&#x02009;9.9 years. The non-valve replacement group had a higher body mass index (BMI) compared to the valve replacement group, with a statistically significant difference (<italic>p</italic>&#x02009;=&#x02009;0.020). There were no statistically significant differences in terms of age, gender, heart rate, smoking history, and drinking history between the two groups. There were no significant differences between the study cohorts in terms of clinical symptoms.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Baseline demographics and clinical variables.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Variables</th><th valign="top" align="center" rowspan="1" colspan="1">Whole cohort (<italic>n</italic>&#x02009;=&#x02009;72)</th><th valign="top" align="center" rowspan="1" colspan="1">Valve replacement group (<italic>n</italic>&#x02009;=&#x02009;30)</th><th valign="top" align="center" rowspan="1" colspan="1">Non-valve replacement group (<italic>n</italic>&#x02009;=&#x02009;42)</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic> value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (year), mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">48.5&#x02009;&#x000b1;&#x02009;9.9</td><td valign="top" align="center" rowspan="1" colspan="1">46.7&#x02009;&#x000b1;&#x02009;10.4</td><td valign="top" align="center" rowspan="1" colspan="1">49.7&#x02009;&#x000b1;&#x02009;9.4</td><td valign="top" align="center" rowspan="1" colspan="1">0.551</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male gender, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">50 (69.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">20 (66.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">30 (71.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.796</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>), mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">25.1&#x02009;&#x000b1;&#x02009;3.2</td><td valign="top" align="center" rowspan="1" colspan="1">24.0&#x02009;&#x000b1;&#x02009;3.2</td><td valign="top" align="center" rowspan="1" colspan="1">25.8&#x02009;&#x000b1;&#x02009;3.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.020*</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Heart rate, mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">82.1&#x02009;&#x000b1;&#x02009;11.2</td><td valign="top" align="center" rowspan="1" colspan="1">81.0&#x02009;&#x000b1;&#x02009;11.3</td><td valign="top" align="center" rowspan="1" colspan="1">82.9&#x02009;&#x000b1;&#x02009;11.2</td><td valign="top" align="center" rowspan="1" colspan="1">0.484</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Smoking, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">21 (29.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (33.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">11 (26.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.602</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Drinking, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">23 (31.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">11 (36.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (28.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.609</td></tr><tr><td valign="top" align="left" colspan="5" rowspan="1">Comorbidity</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hypertension, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">49 (68.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">15 (50.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">34 (81.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.010*</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hypercholesterolaemia, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">11 (15.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (13.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.753</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Diabetes, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (5.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (7.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.636</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CAD, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (6.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (9.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.393</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CVD, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (2.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">2 (4.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.507</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CKD, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0.417</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Marfan syndrome, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (4.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (10.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0.068</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Bicuspid aortic valve, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (6.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (13.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (2.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.153</td></tr><tr><td valign="top" align="left" colspan="5" rowspan="1">Symptoms</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Chest pain, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">63 (87.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">28 (93.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">35 (83.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.289</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Back pain, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">31 (43.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (40.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">19 (45.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.810</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Abdominal pain, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">21 (29.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (33.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">11 (26.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.602</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Headache or coma, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (4.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (6.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (2.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.567</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Limb pain, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (8.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (13.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (4.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.227</td></tr></tbody></table><table-wrap-foot><fn id="table-fn1"><p>Note: Data are presented as the mean&#x02009;&#x000b1;&#x02009;standard deviation (SD) or <italic>n</italic> (%). BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; CAD, coronary artery disease; CVD, cerebrovascular disease; CKD, chronic kidney disease.</p></fn><fn id="table-fn1a"><p>*Denotes a significant difference between the samples (<italic>p</italic> &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b"><label>3.2</label><title>Preoperative and postoperative imaging features</title><p>Detailed CTA and echocardiography characteristics of baseline aortic dissection anatomy are shown in <xref rid="T2" ref-type="table">Table&#x000a0;2</xref>. There were no statistically significant differences between the two groups in terms of the location and diameter of the primary entry tear, number of tears, length of aortic dissection, aortic tortuosity. Additionally, within the entire cohort, both groups exhibited signs of complex dissections such as branches originating from the FL, annular tear, compression of the TL, and malperfusion, but these signs did not differ significantly between the two groups. Regarding the extent of involvement in aortic dissection, the most common locations affected in the distal dissection were the common iliac artery (27.8%) and the external iliac artery (33.3%).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Preoperative and postoperative imaging features.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Variables</th><th valign="top" align="center" rowspan="1" colspan="1">Whole cohort (n&#x02009;=&#x02009;72)</th><th valign="top" align="center" rowspan="1" colspan="1">Valve replacement group (<italic>n</italic>&#x02009;=&#x02009;30)</th><th valign="top" align="center" rowspan="1" colspan="1">Non-valve replacement group (<italic>n</italic>&#x02009;=&#x02009;42)</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic> value</th></tr></thead><tbody><tr><td valign="top" align="left" colspan="5" rowspan="1">Location of primary entry tear</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Aortic root, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">19 (26.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (30.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (23.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.596</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Ascending aorta, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">22 (30.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">11 (36.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">11 (26.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.438</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Transverse arch, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">25 (34.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (23.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (29.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.132</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Proximal descending aorta, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (8.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (10.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (7.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.688</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Diameter of primary entry tear (mm), mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">16.2&#x02009;&#x000b1;&#x02009;10.1</td><td valign="top" align="center" rowspan="1" colspan="1">18.5&#x02009;&#x000b1;&#x02009;10.6</td><td valign="top" align="center" rowspan="1" colspan="1">14.6&#x02009;&#x000b1;&#x02009;9.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.108</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Number of tears, mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">4.8&#x02009;&#x000b1;&#x02009;1.5</td><td valign="top" align="center" rowspan="1" colspan="1">4.9&#x02009;&#x000b1;&#x02009;1.6</td><td valign="top" align="center" rowspan="1" colspan="1">4.7&#x02009;&#x000b1;&#x02009;1.5</td><td valign="top" align="center" rowspan="1" colspan="1">0.592</td></tr><tr><td valign="top" align="left" colspan="5" rowspan="1">Dissection extends to abdominal branches</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Coeliac trunk, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (5.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (6.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (4.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003e;0.999</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SMA, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (6.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (10.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (4.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.643</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RA, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (13.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (10.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.506</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Distal abdominal aorta, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (12.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (6.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.289</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Common iliac artery, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">20 (27.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (40.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (19.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.065</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">External iliac artery, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">24 (33.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (26.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">16 (38.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.447</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Branches originating form FL, mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">3.1&#x02009;&#x000b1;&#x02009;1.8</td><td valign="top" align="center" rowspan="1" colspan="1">3.3&#x02009;&#x000b1;&#x02009;1.9</td><td valign="top" align="center" rowspan="1" colspan="1">3.0&#x02009;&#x000b1;&#x02009;1.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.411</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Malperfusion, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003e;0.999</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Myocardial ischemia, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (2.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (2.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003e;0.999</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cerebral ischemia, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (6.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (9.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.393</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Visceral ischemia, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (4.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (6.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (2.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.567</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Renal failure, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (6.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (10.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (4.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.643</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Lower extremity ischemia, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (6.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (9.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.393</td></tr><tr><td valign="top" align="left" colspan="5" rowspan="1">Aortic regurgitation</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mild, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">22 (30.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">17 (40.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.039*</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Moderate, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">26 (36.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (40.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (33.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.623</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Severe, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">15 (20.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (43.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (4.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.000*</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">LVEF (%), mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">60.3&#x02009;&#x000b1;&#x02009;2.4</td><td valign="top" align="center" rowspan="1" colspan="1">59.6&#x02009;&#x000b1;&#x02009;3.0</td><td valign="top" align="center" rowspan="1" colspan="1">60.7&#x02009;&#x000b1;&#x02009;1.7</td><td valign="top" align="center" rowspan="1" colspan="1">0.051</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Length of aortic dissection(mm), mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">558.8&#x02009;&#x000b1;&#x02009;96.6</td><td valign="top" align="center" rowspan="1" colspan="1">561.6&#x02009;&#x000b1;&#x02009;95.1</td><td valign="top" align="center" rowspan="1" colspan="1">556.9&#x02009;&#x000b1;&#x02009;98.8</td><td valign="top" align="center" rowspan="1" colspan="1">0.840</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Tortuosity, mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">1.2&#x02009;&#x000b1;&#x02009;0.1</td><td valign="top" align="center" rowspan="1" colspan="1">1.1&#x02009;&#x000b1;&#x02009;0.1</td><td valign="top" align="center" rowspan="1" colspan="1">1.2&#x02009;&#x000b1;&#x02009;0.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.164</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Annular tear, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">28 (38.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (43.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">15 (35.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.625</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Preoperative TL compression, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (11.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (7.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.265</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Postoperative TL compression, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (2.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (2.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003e;0.999</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Preoperative maximum descending aorta diameter (mm), mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">30.6&#x02009;&#x000b1;&#x02009;4.7</td><td valign="top" align="center" rowspan="1" colspan="1">30.1&#x02009;&#x000b1;&#x02009;4.0</td><td valign="top" align="center" rowspan="1" colspan="1">30.9&#x02009;&#x000b1;&#x02009;5.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.505</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Postoperative maximum descending aorta diameter (mm), mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">30.6&#x02009;&#x000b1;&#x02009;4.8</td><td valign="top" align="center" rowspan="1" colspan="1">31.2&#x02009;&#x000b1;&#x02009;4.7</td><td valign="top" align="center" rowspan="1" colspan="1">30.1&#x02009;&#x000b1;&#x02009;4.9</td><td valign="top" align="center" rowspan="1" colspan="1">0.364</td></tr></tbody></table><table-wrap-foot><fn id="table-fn2"><p>Note: Data are presented as the mean&#x02009;&#x000b1;&#x02009;standard deviation (SD) or <italic>n</italic> (%). SMA, superior mesenteric artery; RA, renal artery; TL, true lumen; FL, false lumen; LVEF, left ventricular ejection fraction.</p></fn><fn id="table-fn2a"><p>*Denotes a significant difference between the samples (<italic>p</italic> &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap><p>Preoperative routine echocardiography was performed to assess aortic valve regurgitation and left ventricular ejection fraction (LVEF). Both groups had normal LVEFs (mean 60.3%&#x02009;&#x000b1;&#x02009;2.4%), with no statistically significant difference. Aortic regurgitation occurred in both groups. However, there were significantly more severe aortic regurgitation (<italic>p</italic>&#x02009;=&#x02009;0.000) and fewer mild aortic regurgitation (<italic>p</italic>&#x02009;=&#x02009;0.039) in the valve-replacement group than in the non-valve replacement group. Preoperative assessment of aortic valve regurgitation also provide basis for the establishment of surgical strategy in this study.</p><p>The observers demonstrated good consistency in the involvement of branch vessels (<italic>k</italic>&#x02009;=&#x02009;0.886), degree of thrombosis (<italic>k</italic>&#x02009;=&#x02009;0.898), and primary entry tear location (<italic>k</italic>&#x02009;=&#x02009;0.866). The Bland-Altman test results showed good consistency between the measurements of the two observers. The deviations for the AL diameter, TL diameter, involvement length, and primary entry tear diameter were 0.100, 0.150, 0.155, and 0.075, respectively, with 95% confidence intervals (CI) of 2.472 to &#x02212;2.272, 1.020 to &#x02212;0.720, 1.066 to &#x02212;0.756, and 0.618 to &#x02212;0.468.</p></sec><sec id="s3c"><label>3.3</label><title>Operative details</title><p>Surgical details for the entire cohort are presented in <xref rid="T3" ref-type="table">Table&#x000a0;3</xref>. The average time from onset of symptoms to surgery was 8.8&#x02009;&#x000b1;&#x02009;14.1 days in the valve replacement group and 7.6&#x02009;&#x000b1;&#x02009;13.7 days in the non-valve replacement group, with no statistically significant difference between the groups. All surgeries were completed successfully. In the valve replacement group, the cardiopulmonary bypass time, aortic cross-clamping time, cardiac arrest time, size of trunk, and intraoperative red blood cell transfusion were 239.8&#x02009;&#x000b1;&#x02009;55.0 min, 145.0&#x02009;&#x000b1;&#x02009;41.5 min, 26.8&#x02009;&#x000b1;&#x02009;14.4&#x02005;min, 26.2&#x02009;&#x000b1;&#x02009;1.2&#x02005;mm, and 6.4&#x02009;&#x000b1;&#x02009;3.4&#x02005;units, respectively. These above values were significantly greater than those in the non-valve replacement group, with statistical significance. All patients had successful stent implant, with the most common distal anchoring position of the stent being the upper thoracic segment (T6&#x02013;T7) in 56.6% of the valve replacement group and 61.9% of the non-valve replacement group, with no statistically significant difference between the groups.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Operative variables.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Variables</th><th valign="top" align="center" rowspan="1" colspan="1">Valve replacement group (<italic>n</italic>&#x02009;=&#x02009;30)</th><th valign="top" align="center" rowspan="1" colspan="1">Non-valve replacement group (<italic>n</italic>&#x02009;=&#x02009;42)</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic> value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Onset to surgery (days), mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">8.8&#x02009;&#x000b1;&#x02009;14.1</td><td valign="top" align="center" rowspan="1" colspan="1">7.6&#x02009;&#x000b1;&#x02009;13.7</td><td valign="top" align="center" rowspan="1" colspan="1">0.711</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CPB time (min), mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">239.8&#x02009;&#x000b1;&#x02009;55.0</td><td valign="top" align="center" rowspan="1" colspan="1">196.5&#x02009;&#x000b1;&#x02009;35.7</td><td valign="top" align="center" rowspan="1" colspan="1">0.0001*</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Aortic cross-clamping time (min), mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">145.0&#x02009;&#x000b1;&#x02009;41.5</td><td valign="top" align="center" rowspan="1" colspan="1">97.5&#x02009;&#x000b1;&#x02009;18.2</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.0001*</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cardiac arrest time (min), mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">26.8&#x02009;&#x000b1;&#x02009;14.4</td><td valign="top" align="center" rowspan="1" colspan="1">21.0&#x02009;&#x000b1;&#x02009;8.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.035*</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Size of trunk (mm), mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">26.2&#x02009;&#x000b1;&#x02009;1.2</td><td valign="top" align="center" rowspan="1" colspan="1">25.3&#x02009;&#x000b1;&#x02009;1.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.001*</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1">Site of distal anastomosis</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Upper thoracic segment (T6&#x02013;T7), <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">17 (56.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">26 (61.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.808</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mid-thoracic segment (T8&#x02013;T10), <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (43.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">16 (38.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.808</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Concomitant procedure, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (26.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (14.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.234</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CABG, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (7.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.265</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mitral valvuloplasty, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0.417</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Tricuspid valvuloplasty, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0.417</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Carotid subclavian bypass, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">2 (4.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.510</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Renal artery PTA, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (2.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003e;0.999</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Caesarean section, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0.417</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1">Blood transfusion</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Red blood cells (unit), mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">6.4&#x02009;&#x000b1;&#x02009;3.4</td><td valign="top" align="center" rowspan="1" colspan="1">4.0&#x02009;&#x000b1;&#x02009;2.4</td><td valign="top" align="center" rowspan="1" colspan="1">0.001*</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fresh frozen plasma (ml), mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">623.0&#x02009;&#x000b1;&#x02009;225.4</td><td valign="top" align="center" rowspan="1" colspan="1">599.3&#x02009;&#x000b1;&#x02009;300.5</td><td valign="top" align="center" rowspan="1" colspan="1">0.716</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Platelets (unit), mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">1.5&#x02009;&#x000b1;&#x02009;0.6</td><td valign="top" align="center" rowspan="1" colspan="1">1.4&#x02009;&#x000b1;&#x02009;0.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.377</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Postoperative complications, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (6.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.289</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Stroke, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">3 (7.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.261</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Lower extremity ischemia, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">3 (7.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.261</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Anastomotic leak, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (6.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (2.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.567</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hospital days (days), mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">21.6&#x02009;&#x000b1;&#x02009;10.9</td><td valign="top" align="center" rowspan="1" colspan="1">19.8&#x02009;&#x000b1;&#x02009;9.2</td><td valign="top" align="center" rowspan="1" colspan="1">0.453</td></tr></tbody></table><table-wrap-foot><fn id="table-fn3"><p>Note: Data are presented as the mean&#x02009;&#x000b1;&#x02009;standard deviation (SD) or <italic>n</italic> (%). CPB, cardiopulmonary bypass; CABG, coronary artery bypass grafting; PTA, percutaneous transluminal angioplasty; NA, not applicable.</p></fn><fn id="table-fn3a"><p>*Denotes a significant difference between the samples (<italic>p</italic> &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap><p>Additionally, concomitant procedures were performed in 14 patients (19.4%): in the valve replacement group, 1 patient underwent simultaneous coronary artery bypass grafting (CABG) and tricuspid valvuloplasty, 4 patients underwent CABG, 1 patient underwent mitral valvuloplasty, 1 patient underwent renal artery percutaneous transluminal angioplasty (PTA), and 1 patient underwent caesarean section; in the non-valve replacement group, 3 patients underwent CABG, 1 patient underwent ascending aortic-femoral bypass, 1 patient underwent carotid subclavian bypass, and 1 patient underwent renal artery PTA. There were no statistically significant differences between the groups in terms of concomitant procedures, postoperative complications, or length of hospital stay.</p></sec><sec id="s3d"><label>3.4</label><title>Aortic remodeling parameters</title><p>Changes in aortic diameters for patients with aortic dissection are presented in <xref rid="T4" ref-type="table">Table&#x000a0;4</xref>. Comparing the preoperative and postoperative diameters of the AL and TL in the two groups, there was an overall increasing trend in both the AL and TL diameter except at the distal level of the stent (i.e., Level L1). Additionally, the degree of change in the proximal level of the AL and TL diameter was greater than that in the distal level. In relation to the increase in TL diameter, the increase in ascending aorta AL diameter was less favorable for remodeling. Regarding postoperative changes in the diameter of AL and TL, there were statistically significant difference in the TL diameter on level 1 and the AL diameter on level 3&#x02013;5 of the valve replacement group. Additionally, the AL and TL diameter on level 1 and TL diameter on level 2 of the non-valve replacement group were statistically difference.</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Changes in diameter of the AL and TL.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Level of aorta</th><th valign="top" align="center" rowspan="1" colspan="1">Group</th><th valign="top" align="center" rowspan="1" colspan="1">AL PO (mm)</th><th valign="top" align="center" rowspan="1" colspan="1">AL FU (mm)</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic> value</th><th valign="top" align="center" rowspan="1" colspan="1">TL PO (mm)</th><th valign="top" align="center" rowspan="1" colspan="1">TL FU (mm)</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic> value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="2" colspan="1">Level 1</td><td valign="top" align="left" rowspan="1" colspan="1">Group A</td><td valign="top" align="center" rowspan="1" colspan="1">29.6&#x02009;&#x000b1;&#x02009;2.8</td><td valign="top" align="center" rowspan="1" colspan="1">27.9&#x02009;&#x000b1;&#x02009;5.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.133</td><td valign="top" align="center" rowspan="1" colspan="1">10.8&#x02009;&#x000b1;&#x02009;4.1</td><td valign="top" align="center" rowspan="1" colspan="1">21.9&#x02009;&#x000b1;&#x02009;6.2</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.0001*</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Group B</td><td valign="top" align="center" rowspan="1" colspan="1">30.1&#x02009;&#x000b1;&#x02009;4.6</td><td valign="top" align="center" rowspan="1" colspan="1">26.4&#x02009;&#x000b1;&#x02009;5.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.0003*</td><td valign="top" align="center" rowspan="1" colspan="1">11.2&#x02009;&#x000b1;&#x02009;5.0</td><td valign="top" align="center" rowspan="1" colspan="1">23.3&#x02009;&#x000b1;&#x02009;4.6</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.0001*</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Level 2</td><td valign="top" align="left" rowspan="1" colspan="1">Group A</td><td valign="top" align="center" rowspan="1" colspan="1">27.0&#x02009;&#x000b1;&#x02009;4.5</td><td valign="top" align="center" rowspan="1" colspan="1">29.1&#x02009;&#x000b1;&#x02009;4.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.066</td><td valign="top" align="center" rowspan="1" colspan="1">10.2&#x02009;&#x000b1;&#x02009;4.7</td><td valign="top" align="center" rowspan="1" colspan="1">11.2&#x02009;&#x000b1;&#x02009;5.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.456</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Group B</td><td valign="top" align="center" rowspan="1" colspan="1">27.6&#x02009;&#x000b1;&#x02009;4.7</td><td valign="top" align="center" rowspan="1" colspan="1">28.7&#x02009;&#x000b1;&#x02009;4.9</td><td valign="top" align="center" rowspan="1" colspan="1">0.274</td><td valign="top" align="center" rowspan="1" colspan="1">11.4&#x02009;&#x000b1;&#x02009;4.1</td><td valign="top" align="center" rowspan="1" colspan="1">15.0&#x02009;&#x000b1;&#x02009;6.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.002*</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Level 3</td><td valign="top" align="left" rowspan="1" colspan="1">Group A</td><td valign="top" align="center" rowspan="1" colspan="1">24.9&#x02009;&#x000b1;&#x02009;1.9</td><td valign="top" align="center" rowspan="1" colspan="1">27.6&#x02009;&#x000b1;&#x02009;3.9</td><td valign="top" align="center" rowspan="1" colspan="1">0.001*</td><td valign="top" align="center" rowspan="1" colspan="1">9.1&#x02009;&#x000b1;&#x02009;4.4</td><td valign="top" align="center" rowspan="1" colspan="1">9.9&#x02009;&#x000b1;&#x02009;4.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.528</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Group B</td><td valign="top" align="center" rowspan="1" colspan="1">26.3&#x02009;&#x000b1;&#x02009;3.9</td><td valign="top" align="center" rowspan="1" colspan="1">27.4&#x02009;&#x000b1;&#x02009;4.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.217</td><td valign="top" align="center" rowspan="1" colspan="1">10.8&#x02009;&#x000b1;&#x02009;4.1</td><td valign="top" align="center" rowspan="1" colspan="1">12.3&#x02009;&#x000b1;&#x02009;5.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.122</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Level 4</td><td valign="top" align="left" rowspan="1" colspan="1">Group A</td><td valign="top" align="center" rowspan="1" colspan="1">23.6&#x02009;&#x000b1;&#x02009;2.0</td><td valign="top" align="center" rowspan="1" colspan="1">25.5&#x02009;&#x000b1;&#x02009;4.3</td><td valign="top" align="center" rowspan="1" colspan="1">0.036*</td><td valign="top" align="center" rowspan="1" colspan="1">10.1&#x02009;&#x000b1;&#x02009;5.3</td><td valign="top" align="center" rowspan="1" colspan="1">10.6&#x02009;&#x000b1;&#x02009;4.5</td><td valign="top" align="center" rowspan="1" colspan="1">0.694</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Group B</td><td valign="top" align="center" rowspan="1" colspan="1">24.6&#x02009;&#x000b1;&#x02009;3.2</td><td valign="top" align="center" rowspan="1" colspan="1">25.8&#x02009;&#x000b1;&#x02009;4.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.187</td><td valign="top" align="center" rowspan="1" colspan="1">11.3&#x02009;&#x000b1;&#x02009;4.5</td><td valign="top" align="center" rowspan="1" colspan="1">11.9&#x02009;&#x000b1;&#x02009;5.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.554</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Level 5</td><td valign="top" align="left" rowspan="1" colspan="1">Group A</td><td valign="top" align="center" rowspan="1" colspan="1">20.8&#x02009;&#x000b1;&#x02009;2.3</td><td valign="top" align="center" rowspan="1" colspan="1">22.6&#x02009;&#x000b1;&#x02009;4.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.048*</td><td valign="top" align="center" rowspan="1" colspan="1">9.3&#x02009;&#x000b1;&#x02009;5.3</td><td valign="top" align="center" rowspan="1" colspan="1">9.8&#x02009;&#x000b1;&#x02009;4.8</td><td valign="top" align="center" rowspan="1" colspan="1">0.706</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Group B</td><td valign="top" align="center" rowspan="1" colspan="1">21.7&#x02009;&#x000b1;&#x02009;2.8</td><td valign="top" align="center" rowspan="1" colspan="1">22.9&#x02009;&#x000b1;&#x02009;4.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.119</td><td valign="top" align="center" rowspan="1" colspan="1">10.8&#x02009;&#x000b1;&#x02009;4.4</td><td valign="top" align="center" rowspan="1" colspan="1">10.6&#x02009;&#x000b1;&#x02009;4.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.871</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Level 6</td><td valign="top" align="left" rowspan="1" colspan="1">Group A</td><td valign="top" align="center" rowspan="1" colspan="1">20.5&#x02009;&#x000b1;&#x02009;3.8</td><td valign="top" align="center" rowspan="1" colspan="1">21.7&#x02009;&#x000b1;&#x02009;4.4</td><td valign="top" align="center" rowspan="1" colspan="1">0.267</td><td valign="top" align="center" rowspan="1" colspan="1">10.6&#x02009;&#x000b1;&#x02009;7.4</td><td valign="top" align="center" rowspan="1" colspan="1">9.5&#x02009;&#x000b1;&#x02009;5.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.512</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Group B</td><td valign="top" align="center" rowspan="1" colspan="1">19.6&#x02009;&#x000b1;&#x02009;2.6</td><td valign="top" align="center" rowspan="1" colspan="1">20.4&#x02009;&#x000b1;&#x02009;3.9</td><td valign="top" align="center" rowspan="1" colspan="1">0.269</td><td valign="top" align="center" rowspan="1" colspan="1">11.8&#x02009;&#x000b1;&#x02009;5.4</td><td valign="top" align="center" rowspan="1" colspan="1">11.3&#x02009;&#x000b1;&#x02009;5.3</td><td valign="top" align="center" rowspan="1" colspan="1">0.645</td></tr></tbody></table><table-wrap-foot><fn id="table-fn4"><p>Note: Data are presented as the mean&#x02009;&#x000b1;&#x02009;standard deviation (SD). Group A, valve replacement group; Group B, non-valve replacement group; AL, aortic lumen; TL, true lumen; PO, preoperative; FU, follow up.</p></fn><fn id="table-fn4a"><p>*Denotes a significant difference between the samples (<italic>p</italic> &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap><p>According to the proposed classification of aortic remodeling, aortic remodeling rate calculations were performed on 72 patients with aortic dissection. Aortic remodeling rates and comparisons between the two groups are shown in <xref rid="T5" ref-type="table">Table&#x000a0;5</xref> and <xref rid="F3" ref-type="fig">Figure&#x000a0;3</xref>. Positive remodeling was more common at the aortic level adjacent to the stent (i.e., Level L1), with rates of 80.0% in the valve replacement group and 92.9% in the non-valve replacement group. As distance from the stent increased, the degree of positive remodeling gradually decreased, with negative remodeling becoming more common than positive remodeling. Comparison of aortic remodeling rates between the two groups of showed that although the valve replacement group showed fewer instances of positive remodeling and more instances of negative remodeling at levels distant from the stent compared to the non-valve replacement group, there was no statistically significant difference in aortic remodeling rates between the groups at each level.</p><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>Aortic remodeling rates for the entire cohort.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th valign="top" align="left" rowspan="2" colspan="1">Level of aorta</th><th valign="top" align="center" colspan="3" rowspan="1">Positive</th><th valign="top" align="center" colspan="3" rowspan="1">Stable</th><th valign="top" align="center" colspan="3" rowspan="1">Negative</th></tr><tr><th valign="top" align="center" rowspan="1" colspan="1">Group A (%)</th><th valign="top" align="center" rowspan="1" colspan="1">Group B (%)</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic> value</th><th valign="top" align="center" rowspan="1" colspan="1">Group A (%)</th><th valign="top" align="center" rowspan="1" colspan="1">Group B (%)</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic> value</th><th valign="top" align="center" rowspan="1" colspan="1">Group A (%)</th><th valign="top" align="center" rowspan="1" colspan="1">Group B (%)</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic> value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Level 1</td><td valign="top" align="center" rowspan="1" colspan="1">24 (80.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">39 (92.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.151</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0.417</td><td valign="top" align="center" rowspan="1" colspan="1">5 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (7.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.265</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Level 2</td><td valign="top" align="center" rowspan="1" colspan="1">7 (23.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (42.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.132</td><td valign="top" align="center" rowspan="1" colspan="1">5 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (7.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.265</td><td valign="top" align="center" rowspan="1" colspan="1">18 (60.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">21 (50.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.475</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Level 3</td><td valign="top" align="center" rowspan="1" colspan="1">5 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">15 (35.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.110</td><td valign="top" align="center" rowspan="1" colspan="1">4 (13.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (9.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.711</td><td valign="top" align="center" rowspan="1" colspan="1">21 (70.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">23 (54.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.227</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Level 4</td><td valign="top" align="center" rowspan="1" colspan="1">7 (23.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">15 (35.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.307</td><td valign="top" align="center" rowspan="1" colspan="1">5 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (11.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.732</td><td valign="top" align="center" rowspan="1" colspan="1">18 (60.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">22 (52.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.632</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Level 5</td><td valign="top" align="center" rowspan="1" colspan="1">6 (20.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (21.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003e;0.999</td><td valign="top" align="center" rowspan="1" colspan="1">7 (23.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.553</td><td valign="top" align="center" rowspan="1" colspan="1">17 (56.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">26 (61.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.808</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Level 6</td><td valign="top" align="center" rowspan="1" colspan="1">6 (20.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (23.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.780</td><td valign="top" align="center" rowspan="1" colspan="1">9 (30.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">15 (35.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.800</td><td valign="top" align="center" rowspan="1" colspan="1">15 (50.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">17 (40.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.476</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total</td><td valign="top" align="center" rowspan="1" colspan="1">12</td><td valign="top" align="center" rowspan="1" colspan="1">19</td><td valign="top" align="center" rowspan="1" colspan="1">0.810</td><td valign="top" align="center" colspan="3" rowspan="1">&#x02014;</td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">23</td><td valign="top" align="center" rowspan="1" colspan="1">0.810</td></tr></tbody></table><table-wrap-foot><fn id="table-fn5"><p>Note: Data are presented as <italic>n</italic> (%). Group A (<italic>n</italic>&#x02009;=&#x02009;20), valve replacement group; Group B (<italic>n</italic>&#x02009;=&#x02009;42), non-valve replacement group.</p></fn></table-wrap-foot></table-wrap><fig position="float" id="F3"><label>Figure 3</label><caption><p>Aortic remodeling rate of valve replacement group <bold>(A)</bold> and non-valve replacement group <bold>(B)</bold>. Green represents positive remodeling, yellow represents stable, and red represents negative remodeling.</p></caption><graphic xlink:href="fcvm-12-1575757-g003" position="float"/></fig><p>The occurrence of FL thrombosis in various segments of the aorta is detailed in <xref rid="T6" ref-type="table">Table&#x000a0;6</xref> and <xref rid="F4" ref-type="fig">Figure&#x000a0;4</xref>. At the last follow-up, the incidence rates of FL thrombosis were 95.8%, 80.6%, 45.8%, 30.6%, 34.7%, and 38.9% for levels L1, L2, L3, L4, L5, and L6, respectively. In general, FL thrombosis rates tended to increase in all segments after surgery in both groups, but statistically significant differences were observed at L1 and L2 levels in the valve replacement group and at L1&#x02013;L3 levels in the non-valve replacement group. Comparing the postoperative thrombosis rate of the two groups, it was found that only the statistical significance was observed in level L3, and there was no statistical difference between the two groups in other levels. Classification based on the degree of FL thrombosis reveals that as sections closer to the stent, the complete occlusion rate of the FL is higher (67.0% in the valve replacement group and 81.0% in the non-valve replacement group), with statistically significant differences. <xref rid="F5" ref-type="fig">Figure&#x000a0;5</xref> shows two typical examples of preoperative and postoperative morphological features of DeBakey I type aortic dissection.</p><table-wrap position="float" id="T6"><label>Table 6</label><caption><p>False lumen thrombosis status.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th valign="top" align="left" rowspan="2" colspan="1">Level of aorta</th><th valign="top" align="center" colspan="3" rowspan="1">Whole cohort</th><th valign="top" align="center" colspan="3" rowspan="1">Valve Replacement group</th><th valign="top" align="center" colspan="3" rowspan="1">Non-valve Replacement group</th></tr><tr><th valign="top" align="center" rowspan="1" colspan="1">PO (%)</th><th valign="top" align="center" rowspan="1" colspan="1">FU (%)</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic> value</th><th valign="top" align="center" rowspan="1" colspan="1">PO (%)</th><th valign="top" align="center" rowspan="1" colspan="1">FU (%)</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic> value</th><th valign="top" align="center" rowspan="1" colspan="1">PO (%)</th><th valign="top" align="center" rowspan="1" colspan="1">FU (%)</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic> value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Level 1</td><td valign="top" align="center" rowspan="1" colspan="1">7 (9.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">69 (95.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.000*</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">29 (96.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.000*</td><td valign="top" align="center" rowspan="1" colspan="1">6 (14.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">40 (95.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.000*</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Level 2</td><td valign="top" align="center" rowspan="1" colspan="1">11 (15.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">58 (80.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.000*</td><td valign="top" align="center" rowspan="1" colspan="1">3 (10.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">23 (76.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.000*</td><td valign="top" align="center" rowspan="1" colspan="1">8 (19.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">35 (83.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.000*</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Level 3</td><td valign="top" align="center" rowspan="1" colspan="1">12 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">33 (45.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.000*</td><td valign="top" align="center" rowspan="1" colspan="1">4 (13.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (30.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.209</td><td valign="top" align="center" rowspan="1" colspan="1">8 (19.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">24 (57.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.000*</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Level 4</td><td valign="top" align="center" rowspan="1" colspan="1">14 (19.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">22 (30.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.178</td><td valign="top" align="center" rowspan="1" colspan="1">5 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (26.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.532</td><td valign="top" align="center" rowspan="1" colspan="1">9 (21.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (33.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.221</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Level 5</td><td valign="top" align="center" rowspan="1" colspan="1">15 (20.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">25 (34.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.093</td><td valign="top" align="center" rowspan="1" colspan="1">7 (23.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (33.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.568</td><td valign="top" align="center" rowspan="1" colspan="1">8 (19.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">15 (35.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.087</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Level 6</td><td valign="top" align="center" rowspan="1" colspan="1">25 (34.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">28 (38.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.730</td><td valign="top" align="center" rowspan="1" colspan="1">10 (33.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (33.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003e;0.999</td><td valign="top" align="center" rowspan="1" colspan="1">15 (35.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (42.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.503</td></tr></tbody></table><table-wrap-foot><fn id="table-fn6"><p>Note: Data are presented as <italic>n</italic> (%). PO, preoperative. FU, follow up.</p></fn><fn id="table-fn6a"><p>*Denotes a significant difference between the samples (<italic>p</italic> &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap><fig position="float" id="F4"><label>Figure 4</label><caption><p>The degree of FL thrombosis in valve replacement group <bold>(A)</bold> and non-valve replacement group <bold>(B)</bold>. The complete obliteration (blue), malabsorption (red), partial thrombosis (green), or no thrombosis (purple) status of FL at the Level 1, Level 2, and Level 3. FL, false lumen; PO, preoperative. FU, follow up.</p></caption><graphic xlink:href="fcvm-12-1575757-g004" position="float"/></fig><fig position="float" id="F5"><label>Figure 5</label><caption><p>Examples of preoperative and postoperative morphological features of DeBakey I type aortic dissection. The cross-sectional and VR images showed that FL thrombosis was observed at the level of the diaphragm in the non-valve replacement group <bold>(A)</bold>, whereas at the level of the distal stent in the valve replacement group <bold>(B)</bold>. Both groups demonstrate a trend of decreased AL diameter in the proximal descending aorta and increased AL diameter in the distal aorta. VR, volume rendering; AL, aortic lumen; TL, true lumen.</p></caption><graphic xlink:href="fcvm-12-1575757-g005" position="float"/></fig></sec></sec><sec sec-type="discussion" id="s4"><label>4</label><title>Discussion</title><p>Sun's procedure has been widely adopted as a first-line treatment for DeBakey I type aortic dissection in China, achieving favorable aortic remodeling by covering the entry tear and facilitating subsequent FL thrombosis (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>). Aortic remodeling can be influenced by various factors (<xref rid="B22" ref-type="bibr">22</xref>), among which the impact of warfarin anticoagulation after aortic valve replacement on medium and long-term outcomes in patients with extensively repaired aortic dissection remains underexplored. This study explores the effects of anticoagulation after aortic valve replacement on medium and long-term vascular remodeling in DeBakey type I aortic dissection. The results showed that post-aortic valve replacement anticoagulation therapy has been proven to affect aortic diameters and FL thrombosis rate in DeBakey type I aortic dissection. However, its impact on aortic remodeling rate is not significant. Overall, anticoagulation therapy appears to be a safe and effective treatment strategy for DeBakey type I aortic dissection. This work is unique in its comprehensive analysis of changes in aortic diameters, aortic remodeling, and FL thrombosis across different segments, emphasizing the importance of continuous aortic monitoring after aortic dissection.</p><p>Previous studies have reported that the incidence of thoracic and abdominal aortic expansion 2 years after aortic dissection repair was 21.6% and 33.3%, respectively (<xref rid="B23" ref-type="bibr">23</xref>). By 5 years post-surgery, the combined incidence of thoracic and abdominal aortic expansion rose sharply to 62.7% (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>). Aortic dilatation is the most common complication of residual aortic dissection following surgical repair. Such complications can lead to persistent FL expansion, the formation of dissecting aneurysms, aortic rupture, or organ ischemia, thereby increasing the risk of reoperation and aorta-related mortality (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>). Previous research has identified several strong predictors of aortic expansion after dissection repair, including the number of dissection tears, ongoing FL perfusion, extent of dissection involvement, position of stent coverage, and age over 60 years (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B27" ref-type="bibr">27</xref>). Some scholars argue that warfarin anticoagulation after aortic valve replacement affects FL thrombosis and remodeling, posing adverse factors for TL formation and FL closure after aortic dissection. In this study, there were no statistically significant differences between the two patient groups in terms of age, number of dissection tears, branches originating from the FL, extent of dissection involvement, aortic tortuosity, or distal position of stent coverage. This research specifically aims to evaluate the impact of anticoagulation after aortic valve replacement on aortic expansion, while mitigating potential confounding factors associated with aortic dissection drivers mentioned above.</p><p>Assessment of morphological changes post-aortic surgery, including alterations in AL, TL, and FL diameters, remains a topic of ongoing debate. Consensus has yet to be reached on which specific parameters (such as diameter, area, volume, or the absolute ratio of AL to TL growth) or thresholds (e.g., a 10% or 20% increase) should be used to define aortic remodeling (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B28" ref-type="bibr">28</xref>). Patterson et al. have demonstrated that diameter measurements correlate well with cross-sectional area and are appropriate tools for assessing aortic remodeling (<xref rid="B29" ref-type="bibr">29</xref>). Liu et al. have proposed using a 10% change in diameter as a threshold to define significant alterations in AL measurements (<xref rid="B3" ref-type="bibr">3</xref>). Based on this, we adopted this approach and applied this cutoff to diameter measurements (<xref rid="B17" ref-type="bibr">17</xref>). Our methodology and cohort are distinctive in several aspects: we conducted multiple measurements at different levels of the aorta rather than at single points, ensured mid- to long- term follow-up (at least 6 months), and collected relatively comprehensive clinical data. Results from this retrospective study indicate varied changes in aortic diameter at different levels. Comparing the preoperative and postoperative diameters of the AL and TL in the two groups, there was an overall increasing trend in both the AL and TL diameter except at the distal level of the stent (i.e., Level L1). Additionally, the degree of change in the proximal level of the AL and TL diameter was greater than that in the distal level. This growth in aortic diameter across multiple areas highlights the ongoing necessity for rigorous, lifelong monitoring of the aorta.</p><p>Unlike previous morphological studies that focused solely on changes in AL, this study also considers the outcome of the TL and quantifies the TL diameter at all levels at the follow-up time point. Alongside AL growth, the TL diameter also increases correspondingly, particularly at the distal end of the stent, with statistically significant differences observed. At this location, the TL is replaced by the stent, thereby promoting an increase in the TL. In non-stented areas, TL diameters increase across all levels, although the extent of dilation gradually decreases. These findings indicate that the effectiveness of the stent diminishes gradually as the aortic descends. The changes in the TL help reduce wall shear stress and pressure, thereby improving hemodynamics and preventing further dissection or re-tearing of the intimal flap postoperatively (<xref rid="B24" ref-type="bibr">24</xref>). Consequently, for patients with preoperative aortic dissection, particularly those with a spiral tear or collapse of the TL, it is advisable to use adjunctive techniques to extend the stent's range to appropriate positions, thereby improving long-term outcomes while balancing the risk of spinal cord ischemia (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>).</p><p>It is important to noted that the process of aortic expansion or remodeling following aortic dissection surgery has not yet been fully explained. Evidence suggests that aortic remodeling can impact the fate of the distal aorta, thereby influencing the need for distal reintervention (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B32" ref-type="bibr">32</xref>). While there is no universally accepted definition or standardized method for measuring aortic remodeling across the literature, it has typically been assessed using cross-sectional and volume index evaluations. Previous studies have reliably shown morphological changes in the thoracic aorta following stent placement (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>). This retrospective study showed that positive remodeling was more common in the stented segment, while negative remodeling becomes more probable as one approaches the distal aorta, consistent with prior research findings (<xref rid="B5" ref-type="bibr">5</xref>). In contrast, this study demonstrated that preoperative aortic valve replacement did not significantly influence aortic remodeling postoperatively, nor does it increase surgery-related complications. These findings suggest that previous risk assessments regarding the prognostic impact of anticoagulation on aortic dissection may have been overestimated. Overall, anticoagulation therapy following aortic valve replacement appears to yield favorable remodeling outcomes for DeBakey Type I aortic dissection.</p><p>Postoperative thrombosis in DeBakey type I aortic dissection is a significant predictor of aortic dilation and long-term survival (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B35" ref-type="bibr">35</xref>). Under the activation of FL thrombosis formation, downstream aortic remodeling may lead to FL contraction and occlusion (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B36" ref-type="bibr">36</xref>). After aortic valve replacement, anticoagulation therapy influences FL thrombosis, which can result in the continuous expansion of the distal FL in aortic dissection. This provides the basis for the observation of aortic remodeling based on FL thrombosis formation (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B38" ref-type="bibr">38</xref>). In the valve replacement group, the incidence of FL thrombosis formation at the distal end of the stent and at the diaphragmatic level was significantly increased postoperatively compared to preoperatively, whereas in the non-valve replacement group, the ratio of thrombosis formation in the FL at the distal end of the stent, diaphragmatic level, and celiac trunk artery level was significantly increased postoperatively, with statistical significance observed in the differences. In the stent segment, TL expands due to the radial force of the stent, simultaneously causing FL contraction or even disappearance, slowing down blood flow into FL, reducing internal pressure, and promoting thrombosis formation in FL (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B36" ref-type="bibr">36</xref>). In all, the incidence of FL thrombosis formation increased in all patients after surgery compared to preoperative trends. A multicenter registry study in Europe reported thrombosis formation rates of 99.3% and 52.6% in covered and uncovered areas of stent implantation after aortic dissection, respectively, with lower thrombosis formation rates in the abdominal aorta at 13.9% (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B39" ref-type="bibr">39</xref>). Compared to our study, the thrombosis formation rate in the distal covered area was as high as 96.8%, consistent with previous research results; however, in our study, the thrombosis formation rate in the diaphragmatic level of the thoracic aorta was 79%, and in the abdominal aorta segment it was 30.6%-46.8%, higher than previous research results, which can be explained by the assessment of mid- to long- term FL thrombosis formation status in our study. In general, except for the higher postoperative FL thrombosis formation rate at the distal stent level (100%) in the valve replacement group compared to the non-valve replacement group, the thrombosis formation rates at other levels were significantly higher in the non-valve replacement group than in the valve replacement group. Furthermore, the diversity of thrombosis formation should be considered, as there were distinct differences in the postoperative FL thrombosis status between the two groups (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B31" ref-type="bibr">31</xref>). The valve replacement group had a significantly higher proportion of absence of thrombosis in the celiac trunk artery segment (<italic>p</italic>&#x02009;=&#x02009;0.0286) than the non-valve replacement group, with no significant difference in thrombosis status between the two groups at other levels. The findings indicate that anticoagulation after aortic valve replacement indeed affects thrombosis formation in the FL postoperatively. However, it is important to note that thrombosis formation is a dynamic process, and the impact on FL thrombus status may be masked. There is a possibility that partial thrombosis could progressively evolve into malabsorption, with a slight but continuous increase in thrombosis formation. This phenomenon warrants further investigation in future studies.</p></sec><sec id="s5"><label>5</label><title>Limitations</title><p>Our current study has several limitations. The most notable of these include its retrospective nature, small number of participants, and single-center design, all of which may pose potential sources of bias. Firstly, this is a retrospective study, selection bias may influence the results. Secondly, the relatively small sample size, coupled with the fact that all patients were from a single center, limits the statistical power and generalizability of the findings. Thirdly, due to the long-term follow-up period being insufficient, longer follow-up is needed in the future to further accumulate data for evaluating aortic remodeling and surgical outcomes. Fourthly, the term &#x0201c;aortic remodeling&#x0201d; lacks a standardized definition and is widely used in the literature (<xref rid="B17" ref-type="bibr">17</xref>), potentially leading to differences in direct comparisons with other studies. In the future, we may attempt to conduct prospective, multicenter, and longer-term follow-up studies to evaluate predictive factors of remodeling status after aortic dissection surgery based on patients' clinical and multimodal imaging data. However, considering our study's results through comprehensive analysis of diameter measurements at multiple levels of the distal aorta and FL status, this research offers high utility in better elucidating the effect of anticoagulation on the aorta remodeling after aortic valve replacement.</p></sec><sec sec-type="conclusions" id="s6"><label>6</label><title>Conclusions</title><p>The results of this study showed that there was no significant correlation between the involvement of the aortic valve and the extent of tear at the distal end of DeBakey type I aortic dissection. Surgery involving Sun's procedure combined with aortic valve replacement compared to Sun's procedure alone resulted in longer operative times, increased red blood cell transfusions, partly affected the diameter of the aorta, and the status of thrombus formation in the FL. However, there was no significant impact on the rate of residual aortic remodeling postoperatively. Anticoagulation therapy appears to be a safe and effective treatment strategy for DeBakey type I aortic dissection. For patients who undergo anticoagulation therapy after aortic dissection, regular follow-up imaging is necessary, with particular attention to aortic dilation or thrombosis.</p></sec></body><back><sec sec-type="data-availability" id="s7"><title>Data availability statement</title><p>The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.</p></sec><sec sec-type="ethics-statement" id="s8"><title>Ethics statement</title><p>The studies involving humans were approved by the ethical committee of Shandong Provincial Hospital (Shandong, China). The studies were conducted in accordance with the local legislation and institutional requirements. The ethics committee/institutional review board waived the requirement of written informed consent for participation from the participants or the participants' legal guardians/next of kin because The protocol for this single-center, retrospective, observational study was approved by the ethical committee of Shandong Provincial Hospital (Shandong, China) (approval number: 20201-361), and the individual written informed consent was waived. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p></sec><sec sec-type="author-contributions" id="s9"><title>Author contributions</title><p>YL: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. SY: Conceptualization, Methodology, Writing &#x02013; review &#x00026; editing. CJ: Conceptualization, Methodology, Writing &#x02013; review &#x00026; editing. HY: Data curation, Funding acquisition, Investigation, Writing &#x02013; review &#x00026; editing. JS: Data curation, Funding acquisition, Resources, Writing &#x02013; review &#x00026; editing. JJ: Funding acquisition, Resources, Writing &#x02013; review &#x00026; editing. XW: Funding acquisition, Supervision, Writing &#x02013; review &#x00026; editing. LW: Conceptualization, Methodology, Investigation, Supervision, Writing &#x02013; review &#x00026; editing.</p></sec><sec sec-type="COI-statement" id="s11"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="s12"><title>Generative AI statement</title><p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="s13"><title>Publisher's note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>FC</given-names></name><name><surname>Ma</surname><given-names>WG</given-names></name><name><surname>Ge</surname><given-names>YP</given-names></name><name><surname>Zhu</surname><given-names>JM</given-names></name><name><surname>Sun</surname><given-names>LZ</given-names></name></person-group>. <article-title>Does preoperative dual antiplatelet therapy affect bleeding and mortality after total arch repair for acute type A dissection?</article-title>
<source>Interact Cardiovasc Thorac Surg</source>. (<year>2022</year>) <volume>34</volume>(<issue>1</issue>):<fpage>120</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1093/icvts/ivab226</pub-id><pub-id pub-id-type="pmid">34999809</pub-id>
</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Lingala</surname><given-names>B</given-names></name><name><surname>Baiocchi</surname><given-names>M</given-names></name><name><surname>Tao</surname><given-names>JJ</given-names></name><name><surname>Toro Arana</surname><given-names>V</given-names></name><name><surname>Khoo</surname><given-names>JW</given-names></name><etal/></person-group>
<article-title>Type A aortic dissection-experience over 5 decades: JACC historical breakthroughs in perspective</article-title>. <source>J Am Coll Cardiol</source>. (<year>2020</year>) <volume>76</volume>(<issue>14</issue>):<fpage>1703</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2020.07.061</pub-id><pub-id pub-id-type="pmid">33004136</pub-id>
</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Xiao</surname><given-names>Z</given-names></name><name><surname>Peng</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>P</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Early endovascular intervention for unfavorable remodeling of the thoracic aorta after open surgery for acute DeBakey type I aortic dissection: study protocol for a multicenter, randomized, controlled trial</article-title>. <source>Trials</source>. (<year>2023</year>) <volume>24</volume>(<issue>1</issue>):<fpage>496</fpage>. <pub-id pub-id-type="doi">10.1186/s13063-023-07548-x</pub-id><pub-id pub-id-type="pmid">37543681</pub-id>
</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hameed</surname><given-names>I</given-names></name><name><surname>Cifu</surname><given-names>AS</given-names></name><name><surname>Vallabhajosyula</surname><given-names>P</given-names></name></person-group>. <article-title>Management of thoracic aortic dissection</article-title>. <source>JAMA</source>. (<year>2023</year>) <volume>329</volume>(<issue>9</issue>):<fpage>756</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2023.0265</pub-id><pub-id pub-id-type="pmid">36795378</pub-id>
</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name></person-group>. <article-title>Preoperative diameters of aorta influence the remodeling after surgery for type A aortic dissection</article-title>. <source>J Thorac Dis</source>. (<year>2023</year>) <volume>15</volume>(<issue>8</issue>):<fpage>4306</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.21037/jtd-23-266</pub-id><pub-id pub-id-type="pmid">37691648</pub-id>
</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loor</surname><given-names>G</given-names></name><name><surname>Gleason</surname><given-names>TG</given-names></name><name><surname>Myrmel</surname><given-names>T</given-names></name><name><surname>Korach</surname><given-names>A</given-names></name><name><surname>Trimarchi</surname><given-names>S</given-names></name><name><surname>Desai</surname><given-names>ND</given-names></name><etal/></person-group>
<article-title>Effect of aortic valve type on patients who undergo type A aortic dissection repair</article-title>. <source>Semin Thorac Cardiovasc Surg</source>. (<year>2022</year>) <volume>34</volume>(<issue>2</issue>):<fpage>479</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1053/j.semtcvs.2021.04.003</pub-id><pub-id pub-id-type="pmid">33984483</pub-id>
</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omura</surname><given-names>A</given-names></name><name><surname>Miyahara</surname><given-names>S</given-names></name><name><surname>Yamanaka</surname><given-names>K</given-names></name><name><surname>Sakamoto</surname><given-names>T</given-names></name><name><surname>Matsumori</surname><given-names>M</given-names></name><name><surname>Okada</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Early and late outcomes of repaired acute DeBakey type I aortic dissection after graft replacement</article-title>. <source>J Thorac Cardiovasc Surg</source>. (<year>2016</year>) <volume>151</volume>(<issue>2</issue>):<fpage>341</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtcvs.2015.03.068</pub-id><pub-id pub-id-type="pmid">26496808</pub-id>
</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Surgical treatment for type A aortic dissection after endovascular aortic repair: a 12-year, single-center study</article-title>. <source>Cardiovasc Drugs Ther</source>. (<year>2024</year>). <pub-id pub-id-type="doi">10.1007/s10557-024-07565-1</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chivasso</surname><given-names>P</given-names></name><name><surname>Mastrogiovanni</surname><given-names>G</given-names></name><name><surname>Bruno</surname><given-names>VD</given-names></name><name><surname>Miele</surname><given-names>M</given-names></name><name><surname>Colombino</surname><given-names>M</given-names></name><name><surname>Triggiani</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Systematic total arch replacement with thoraflex hybrid graft in acute type A aortic dissection: a single centre experience</article-title>. <source>Front Cardiovasc Med</source>. (<year>2022</year>) <volume>9</volume>:<fpage>997961</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2022.997961</pub-id><pub-id pub-id-type="pmid">36312248</pub-id>
</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>H</given-names></name><name><surname>Fukada</surname><given-names>J</given-names></name><name><surname>Tamiya</surname><given-names>Y</given-names></name><name><surname>Mikami</surname><given-names>T</given-names></name></person-group>. <article-title>Morphometric predictors of aortic remodeling after frozen elephant trunk repair of type A dissection</article-title>. <source>Ann Vasc Surg</source>. (<year>2022</year>) <volume>84</volume>:<fpage>179</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.avsg.2022.01.007</pub-id><pub-id pub-id-type="pmid">35108558</pub-id>
</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaneyuki</surname><given-names>D</given-names></name><name><surname>Mogi</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Otsu</surname><given-names>M</given-names></name><name><surname>Sakurai</surname><given-names>M</given-names></name><name><surname>Takahara</surname><given-names>Y</given-names></name></person-group>. <article-title>The frozen elephant trunk technique for acute retrograde type A aortic dissection: preliminary results</article-title>. <source>Interact Cardiovasc Thorac Surg</source>. (<year>2020</year>) <volume>31</volume>(<issue>6</issue>):<fpage>813</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/icvts/ivaa199</pub-id><pub-id pub-id-type="pmid">33164059</pub-id>
</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Gu</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Cheng</surname><given-names>Z</given-names></name><name><surname>Duan</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Dynamic indicators that impact the outcomes of thoracic endovascular aortic repair in complicated type B aortic dissection</article-title>. <source>J Vasc Interv Radiol</source>. (<year>2020</year>) <volume>31</volume>(<issue>5</issue>):<fpage>760</fpage>&#x02013;<lpage>8.e1</lpage>. <pub-id pub-id-type="doi">10.1016/j.jvir.2019.11.010</pub-id><pub-id pub-id-type="pmid">31982315</pub-id>
</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Preoperative predictors of late aortic expansion in acute type B aortic dissection treated with TEVAR</article-title>. <source>J Clin Med</source>. (<year>2023</year>) <volume>12</volume>(<issue>8</issue>):<fpage>2826</fpage>. <pub-id pub-id-type="doi">10.3390/jcm12082826</pub-id><pub-id pub-id-type="pmid">37109163</pub-id>
</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blakeslee-Carter</surname><given-names>J</given-names></name><name><surname>Potter</surname><given-names>HA</given-names></name><name><surname>Banks</surname><given-names>CA</given-names></name><name><surname>Passman</surname><given-names>M</given-names></name><name><surname>Pearce</surname><given-names>B</given-names></name><name><surname>McFarland</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Aortic visceral segment instability is evident following thoracic endovascular aortic repair for acute and subacute type B aortic dissection</article-title>. <source>J Vasc Surg</source>. (<year>2022</year>) <volume>76</volume>(<issue>2</issue>):<fpage>389</fpage>&#x02013;<lpage>99.e1</lpage>. <pub-id pub-id-type="doi">10.1016/j.jvs.2022.02.046</pub-id><pub-id pub-id-type="pmid">35276262</pub-id>
</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lombardi</surname><given-names>JV</given-names></name><name><surname>Hughes</surname><given-names>GC</given-names></name><name><surname>Appoo</surname><given-names>JJ</given-names></name><name><surname>Bavaria</surname><given-names>JE</given-names></name><name><surname>Beck</surname><given-names>AW</given-names></name><name><surname>Cambria</surname><given-names>RP</given-names></name><etal/></person-group>
<article-title>Society for vascular surgery (SVS) and society of thoracic surgeons (STS) reporting standards for type B aortic dissections</article-title>. <source>J Vasc Surg</source>. (<year>2020</year>) <volume>71</volume>(<issue>3</issue>):<fpage>723</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.jvs.2019.11.013</pub-id><pub-id pub-id-type="pmid">32001058</pub-id>
</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Fang</surname><given-names>C</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Wei</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Short-term follow-up of proximal aorta remodeling after zone 2 thoracic endovascular aortic repair for acute type B aortic dissection</article-title>. <source>Int J Cardiol</source>. (<year>2023</year>) <volume>393</volume>:<fpage>131393</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2023.131393</pub-id><pub-id pub-id-type="pmid">37748525</pub-id>
</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iafrancesco</surname><given-names>M</given-names></name><name><surname>Goebel</surname><given-names>N</given-names></name><name><surname>Mascaro</surname><given-names>J</given-names></name><name><surname>Franke</surname><given-names>UFW</given-names></name><name><surname>Pacini</surname><given-names>D</given-names></name><name><surname>Di Bartolomeo</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Aortic diameter remodelling after the frozen elephant trunk technique in aortic dissection: results from an international multicentre registry</article-title>. <source>Eur J Cardiothorac Surg</source>. (<year>2017</year>) <volume>52</volume>(<issue>2</issue>):<fpage>310</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/ejcts/ezx131</pub-id><pub-id pub-id-type="pmid">28575324</pub-id>
</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Cai</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group>. <article-title>Clinical outcomes and aortic remodeling after castor single-branched stent-graft implantation for type B aortic dissections involving left subclavian artery</article-title>. <source>Front Cardiovasc Med</source>. (<year>2024</year>) <volume>11</volume>:<fpage>1370908</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2024.1370908</pub-id><pub-id pub-id-type="pmid">38873267</pub-id>
</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>D</given-names></name><name><surname>Yi</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>A new minimal invasive technique with <italic>in situ</italic> stent-graft fenestration for type A aortic dissection</article-title>. <source>Heliyon</source>. (<year>2024</year>) <volume>10</volume>(<issue>7</issue>):<fpage>e29106</fpage>. <pub-id pub-id-type="doi">10.1016/j.heliyon.2024.e29106</pub-id><pub-id pub-id-type="pmid">38601613</pub-id>
</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Risk factors for early death after surgery in patients with acute Stanford type A aortic dissection: a systematic review and meta-analysis</article-title>. <source>Int J Cardiol</source>. (<year>2023</year>) <volume>377</volume>:<fpage>33</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2022.12.013</pub-id><pub-id pub-id-type="pmid">36513283</pub-id>
</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papakonstantinou</surname><given-names>NA</given-names></name><name><surname>Martinez-Lopez</surname><given-names>D</given-names></name><name><surname>Chung</surname><given-names>JC</given-names></name></person-group>. <article-title>The frozen elephant trunk: seeking a more definitive treatment for acute type A aortic dissection</article-title>. <source>Eur J Cardiothorac Surg</source>. (<year>2024</year>) <volume>65</volume>(<issue>5</issue>):<fpage>ezae176</fpage>. <pub-id pub-id-type="doi">10.1093/ejcts/ezae176</pub-id><pub-id pub-id-type="pmid">38676575</pub-id>
</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vecchini</surname><given-names>F</given-names></name><name><surname>Haupert</surname><given-names>G</given-names></name><name><surname>Baudry</surname><given-names>A</given-names></name><name><surname>Mancini</surname><given-names>J</given-names></name><name><surname>Dumur</surname><given-names>L</given-names></name><name><surname>Martinez</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Risk factors for incomplete aortic remodeling with stent-assisted balloon-induced intimal disruption and relamination in aortic dissection repair for complicated aortic dissection: results of a multicenter study</article-title>. <source>J Endovasc Ther</source>. (<year>2024</year>) <volume>31</volume>(<issue>1</issue>):<fpage>69</fpage>&#x02013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1177/15266028221111984</pub-id><pub-id pub-id-type="pmid">35880296</pub-id>
</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Ge</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Altered aortic arch geometry in patients with type B aortic dissection</article-title>. <source>Eur J Cardiothorac Surg</source>. (<year>2020</year>) <volume>58</volume>(<issue>4</issue>):<fpage>714</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1093/ejcts/ezaa102</pub-id><pub-id pub-id-type="pmid">32303067</pub-id>
</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porto</surname><given-names>A</given-names></name><name><surname>Omnes</surname><given-names>V</given-names></name><name><surname>Bartoli</surname><given-names>MA</given-names></name><name><surname>Azogui</surname><given-names>R</given-names></name><name><surname>Resseguier</surname><given-names>N</given-names></name><name><surname>De Masi</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Reintervention of residual aortic dissection after type A aortic repair: results of a prospective follow-up at 5 years</article-title>. <source>J Clin Med</source>. (<year>2023</year>) <volume>12</volume>(<issue>6</issue>):<fpage>2363</fpage>. <pub-id pub-id-type="doi">10.3390/jcm12062363</pub-id><pub-id pub-id-type="pmid">36983363</pub-id>
</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Incidence, predictors, and implications of secondary aortic intervention following thoracic endovascular aortic repair for type B dissection</article-title>. <source>J Endovasc Ther</source>. (<year>2024</year>). <pub-id pub-id-type="doi">10.1177/15266028241255549</pub-id><pub-id pub-id-type="pmid">38804527</pub-id>
</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marn&#x000e9;</surname><given-names>E</given-names></name><name><surname>Guimbreti&#x000e8;re</surname><given-names>G</given-names></name><name><surname>Mougin</surname><given-names>J</given-names></name><name><surname>Le Corvec</surname><given-names>T</given-names></name><name><surname>Guyomarch</surname><given-names>B</given-names></name><name><surname>De Beaufort</surname><given-names>LM</given-names></name><etal/></person-group>
<article-title>Comparison of short and midterm aortic reinterventions in acute type A aortic dissection treated by frozen elephant trunk or conventional arch repair</article-title>. <source>Ann Vasc Surg</source>. (<year>2023</year>) <volume>95</volume>:<fpage>3</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.avsg.2023.05.001</pub-id><pub-id pub-id-type="pmid">37169252</pub-id>
</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutarjono</surname><given-names>B</given-names></name><name><surname>Ahmed</surname><given-names>AJ</given-names></name><name><surname>Ivanova</surname><given-names>A</given-names></name><name><surname>Buchel</surname><given-names>B</given-names></name><name><surname>Rauscher</surname><given-names>J</given-names></name><name><surname>O&#x02019;Connell</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Diagnostic accuracy of transthoracic echocardiography for the identification of proximal aortic dissection: a systematic review and meta-analysis</article-title>. <source>Sci Rep</source>. (<year>2023</year>) <volume>13</volume>(<issue>1</issue>):<fpage>5886</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-023-32800-4</pub-id><pub-id pub-id-type="pmid">37041307</pub-id>
</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghazy</surname><given-names>A</given-names></name><name><surname>Chaban</surname><given-names>R</given-names></name><name><surname>Pfeiffer</surname><given-names>P</given-names></name><name><surname>Probst</surname><given-names>C</given-names></name><name><surname>Dohle</surname><given-names>D-S</given-names></name><name><surname>Treede</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Three-dimensional-evaluation of aortic changes after frozen elephant trunk (FET) in zone 0 vs. zone 2 in acute type A aortic dissection</article-title>. <source>J Clin Med</source>. (<year>2024</year>) <volume>13</volume>(<issue>9</issue>):<fpage>2677</fpage>. <pub-id pub-id-type="doi">10.3390/jcm13092677</pub-id><pub-id pub-id-type="pmid">38731205</pub-id>
</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>BO</given-names></name><name><surname>Vidal-Diez</surname><given-names>A</given-names></name><name><surname>Karthikesalingam</surname><given-names>A</given-names></name><name><surname>Holt</surname><given-names>PJ</given-names></name><name><surname>Loftus</surname><given-names>IM</given-names></name><name><surname>Thompson</surname><given-names>MM</given-names></name></person-group>. <article-title>Comparison of aortic diameter and area after endovascular treatment of aortic dissection</article-title>. <source>Ann Thorac Surg</source>. (<year>2015</year>) <volume>99</volume>(<issue>1</issue>):<fpage>95</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/j.athoracsur.2014.08.022</pub-id><pub-id pub-id-type="pmid">25440284</pub-id>
</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000f6;bel</surname><given-names>N</given-names></name><name><surname>Holder</surname><given-names>S</given-names></name><name><surname>H&#x000fc;ther</surname><given-names>F</given-names></name><name><surname>Anguelov</surname><given-names>Y</given-names></name><name><surname>Bail</surname><given-names>D</given-names></name><name><surname>Franke</surname><given-names>U</given-names></name></person-group>. <article-title>Frozen elephant trunk versus conventional proximal repair of acute aortic dissection type I</article-title>. <source>Front Cardiovasc Med</source>. (<year>2024</year>) <volume>11</volume>:<fpage>1326124</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2024.1326124</pub-id><pub-id pub-id-type="pmid">38559669</pub-id>
</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Xiang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Long-term aortic remodeling after thoracic endovascular aortic repair of acute, subacute, and chronic type B dissections</article-title>. <source>Front Cardiovasc Med</source>. (<year>2022</year>) <volume>9</volume>:<fpage>819501</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2022.819501</pub-id><pub-id pub-id-type="pmid">35433882</pub-id>
</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnaoutakis</surname><given-names>DJ</given-names></name><name><surname>Khan</surname><given-names>TA</given-names></name><name><surname>Scali</surname><given-names>ST</given-names></name><name><surname>Neal</surname><given-names>D</given-names></name><name><surname>Giles</surname><given-names>KA</given-names></name><name><surname>Cooper</surname><given-names>MA</given-names></name><etal/></person-group>
<article-title>Remodeling, reintervention, and survival after endovascular repair of chronic type B dissection</article-title>. <source>Ann Thorac Surg</source>. (<year>2021</year>) <volume>111</volume>(<issue>5</issue>):<fpage>1560</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.athoracsur.2020.07.017</pub-id><pub-id pub-id-type="pmid">32961141</pub-id>
</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Mastrodicasa</surname><given-names>D</given-names></name><name><surname>Al Bulushi</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>MC</given-names></name><name><surname>Tse</surname><given-names>JR</given-names></name><name><surname>Watkins</surname><given-names>AC</given-names></name><etal/></person-group>
<article-title>Thoracic endovascular aortic repair for chronic type B aortic aissection: pre- and postprocedural imaging</article-title>. <source>Radiographics</source>. (<year>2022</year>) <volume>42</volume>(<issue>6</issue>):<fpage>1638</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1148/rg.220028</pub-id><pub-id pub-id-type="pmid">36190862</pub-id>
</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hari</surname><given-names>Y</given-names></name><name><surname>Takagi</surname><given-names>H</given-names></name></person-group>. <article-title>Urgent thoracic endovascular aortic repair for type-B0, D acute aortic dissection</article-title>. <source>Ann Vasc Surg</source>. (<year>2024</year>) <volume>109</volume>:<fpage>1</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.avsg.2024.05.025</pub-id><pub-id pub-id-type="pmid">39025222</pub-id>
</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Chang</surname><given-names>HW</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Lim</surname><given-names>C</given-names></name><name><surname>Park</surname><given-names>KH</given-names></name></person-group>. <article-title>Can preoperative features predict residual false lumen remodelling after tear-oriented limited resection for acute type I dissection?</article-title>
<source>Eur J Cardiothorac Surg</source>. (<year>2022</year>) <volume>62</volume>(<issue>3</issue>):<fpage>ezac097</fpage>. <pub-id pub-id-type="doi">10.1093/ejcts/ezac097</pub-id><pub-id pub-id-type="pmid">35262684</pub-id>
</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz-Mu&#x000f1;oz</surname><given-names>A</given-names></name><name><surname>Guala</surname><given-names>A</given-names></name><name><surname>Dux-Santoy</surname><given-names>L</given-names></name><name><surname>Teixid&#x000f3;-Tur&#x000e0;</surname><given-names>G</given-names></name><name><surname>Valente</surname><given-names>F</given-names></name><name><surname>Garrido-Oliver</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>False lumen hemodynamics and partial thrombosis in chronic aortic dissection of the descending aorta</article-title>. <source>Eur Radiol</source>. (<year>2024</year>) <volume>34</volume>(<issue>8</issue>):<fpage>5190</fpage>&#x02013;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1007/s00330-023-10513-6</pub-id><pub-id pub-id-type="pmid">38183450</pub-id>
</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onalan</surname><given-names>A</given-names></name><name><surname>Gurkas</surname><given-names>E</given-names></name><name><surname>Kursad Akpinar</surname><given-names>C</given-names></name><name><surname>Aykac</surname><given-names>O</given-names></name><name><surname>Uysal Kocabas</surname><given-names>Z</given-names></name><name><surname>Dogan</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Safety and effectiveness of anticoagulation in the management of acute stroke and transient ischemic attack due to intracranial and extracranial non-occlusive thrombus</article-title>. <source>J Clin Neurosci</source>. (<year>2024</year>) <volume>124</volume>:<fpage>47</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.jocn.2024.04.012</pub-id><pub-id pub-id-type="pmid">38643651</pub-id>
</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishizue</surname><given-names>N</given-names></name><name><surname>Fukaya</surname><given-names>H</given-names></name><name><surname>Oikawa</surname><given-names>J</given-names></name><name><surname>Sato</surname><given-names>N</given-names></name><name><surname>Ogiso</surname><given-names>S</given-names></name><name><surname>Murayama</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Prognostic impact of oral anticoagulation therapy and atrial fibrillation in patients with type B acute aortic dissection</article-title>. <source>J Arrhythm</source>. (<year>2024</year>) <volume>40</volume>(<issue>2</issue>):<fpage>297</fpage>&#x02013;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1002/joa3.13020</pub-id><pub-id pub-id-type="pmid">38586850</pub-id>
</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Dun</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Hybrid technique on the total arch replacement for type A aortic dissection: 12-year clinical and radiographical outcomes from a single center</article-title>. <source>Front Cardiovasc Med</source>. (<year>2022</year>) <volume>9</volume>:<fpage>820653</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2022.820653</pub-id><pub-id pub-id-type="pmid">35295249</pub-id>
</mixed-citation></ref></ref-list></back></article>